$3.45
+0.15 (+4.55%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+135.4% upside
Low Target
$6.66
Average Target
$8.12
High Target
$12.47
Current Price
$3.45
Current
$3.45
$3.45
Target
$8.12
$8.12
$6.66
$8.12 avg
$12.47
Scenario Analysis
Bear Case
$6.66
93.0%
Low target
Base Case
$8.12
+135.4%
Avg target
Bull Case
$12.47
+261.4%
High target
Risk/Reward
2.8x
Favorable
Price in Context
52-Week High
$9.12
-62.2% from high
52-Week Low
$3.53
+-2.3% from low
Target vs 52W High
$8.12
-11.0% vs high
Next Earnings Report
Nov 11, 2026
4d
until earnings
EPS Est: $-0.63
Earnings in 4 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals